Brief: Moberg Pharma Q4 EBITDA Loss Narrows To SEK 7.8 Mln

Moberg Pharma AB (publ)

11/02/2025 07:03

Feb 11 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * Q4 NET REVENUE SEK 1.0 MILLION (0)
    * Q4 EBITDA SEK -7.8 MILLION (-8.0)

Source text:  ID:nWkr4hrVGd 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))